AI Article Synopsis
- HIV-associated neurocognitive disorders (HAND) affect cognitive functions like attention and memory in people with HIV, despite a decrease in incidence due to improved treatments.
- The diagnosis of HAND relies on neurocognitive tests, which can be subjective; therefore, there's a critical need for more accurate biomarkers.
- Advances in multimodal brain imaging, particularly the combination of EEG and fMRI, offer a promising approach to uncovering the mechanisms of HAND and may enable earlier diagnosis and better treatment options for affected patients.
Article Abstract
HIV-associated neurocognitive disorders (HAND) are one of the common complications in people living with HIV (PLWH), which can affect their attention, working memory, and other related cognitive functions. With the widespread use of combination antiretroviral therapy (cART), the incidence of HAND has declined. However, HAND is still an important complication of HIV, which not only affects the quality of life of patients but also affects their adherence to HIV treatment. Its diagnosis mainly relies on neurocognitive tests, which have a certain degree of subjectivity, making it difficult to diagnose and classify HAND accurately, and there is an urgent need to explore more sensitive biomarkers. Multimodal brain imaging has seen a surge in recent years with simultaneous EEG-fMRI being at the forefront of cognitive multimodal neuroimaging. It is a complementary fusion technique that effectively combines the high spatial resolution of fMRI with the high temporal resolution of EEG, compensating for the shortcomings of a single technique and providing a new method for studying cognitive function. It is expected to reveal the underlying mechanisms of HAND and provide high spatiotemporal warning biomarkers of HAND, which will provide a new perspective for the early diagnosis and treatment of HAND and contribute to the improvement of patient prognosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11655344 | PMC |
| http://dx.doi.org/10.3389/fneur.2024.1479197 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice.
J Vis Exp
December 2024
Cognitive and Neural Sciences, Department of Psychology, University of South Carolina;
Article Synopsis
- Combined antiretroviral therapy (cART) has significantly enhanced the quality of life for people living with HIV (PLWH), but many older adults face HIV-associated neurocognitive disorders (HAND).
- A new biological model using chimeric HIV (EcoHIV) has been developed in rats to study the neurological effects of HIV, but understanding its distribution in the brain remains a challenge.
- In this study, EcoHIV was modified and injected into mice to investigate whether microglia are the primary cells containing HIV; results show that microglia are indeed the main reservoirs for HIV in the brain, highlighting the model's potential for exploring neurocognitive disorders.
Patient-specific brain fluorodeoxyglucose positron emission tomography can detect the first effects of combination antiretroviral therapy in patient with HIV infection.
Glob Health Med
December 2024
Department of AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Article Synopsis
- Patient-specific FDG PET can identify abnormal brain activity in HIV patients before and after starting combination antiretroviral therapy (cART).
- Studies on these changes were limited to a small number of patients and timeframes.
- The analysis found that abnormal FDG uptake areas decreased significantly after 6 months of cART, suggesting FDG PET may be useful for early monitoring of treatment effects.
Generating fair, reliable, and accurate neuropsychological test norms for people with HIV in a low- or middle-income country.
J Neurovirol
December 2024
HIV Center for Clinical and Behavioral Science, New York State Psychiatric Institute and Columbia University, New York, NY, USA.
Effective neuropsychological assessment of people with HIV (PWH) in low- and middle-income countries (LMICs) is hampered by the unavailability of adequate test norms. We aimed to: (1) develop demographically-corrected (regression-based) South African (SA) normative data for an HIV appropriate neuropsychological test battery for Xhosa home-language speakers; (2) compare the utility of those norms to that of (i) internal standardization norms and (ii) US test publisher norms; and (3) determine the criterion validity of the newly-developed norms. 114 controls and 102 demographically comparable Xhosa home-language people living with HIV completed a well-establised, standard HIV neuropsychological test battery assessing seven cognitive domains.
View Article and Find Full Text PDFInnate immune memory in chronic HIV and HIV-associated neurocognitive disorders (HAND): potential mechanisms and clinical implications.
J Neurovirol
December 2024
Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, 19102, USA.
Although antiretroviral therapy (ART) has dramatically improved the outlook of the HIV/AIDS pandemic, people living with HIV (PLWH) on suppressive therapy are still at higher risk for a range of comorbidities including cardiovascular disease (CVD) and HIV-associated neurocognitive disorders (HAND), among others. Chronic inflammation and immune activation are thought to be an underlying cause of these comorbidities. Many of the factors thought to drive chronic inflammation and immune activation in HIV overlap with factors known to induce trained immunity.
View Article and Find Full Text PDFp62 Binding to Protein Kinase C Regulates HIV-1 gp120 V3 Loop Induced Microglial Inflammation.
Inflammation
December 2024
Department of Pathophysiology, Key Laboratory of the State Administration of Traditional Chinese Medicine, Medical College of Jinan University, Guangzhou, Guangdong Province, China.
The main pathogenic mechanism of HIV-associated neurocognitive disorders (HAND) is neuronal apoptosis induced by inflammatory mediators, in which microglial inflammation plays a crucial role. However, the exact pathogenic mechanism remains unclear. Previous studies have shown that the HIV-1 gp120 V3 loop can trigger inflammation in CHME-5 microglia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!